There are currently no established pharmacogenetic interactions between the gene MEX3C and specific drugs; however, given its significant role in regulating immune responses and potential involvement in tumorigenesis, MEX3C may influence the efficacy of immunomodulatory therapies and cancer treatments. Understanding the expression levels or genetic variants of MEX3C could be crucial for personalized treatment strategies in these areas in the future.